Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Skull Base Neoplasms 1Patients Who Are Treated With Tyrosine Kinase Inhibitors 1Anosmia 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Olfactory Training × 1 year × Clear all
NCT05912881 2026-02-18

Chemosensory Dysfunction and Recovery in Endoscopic Endonasal Skull Base Surgery

Johns Hopkins University

Phase NA Completed
41 enrolled

Anosmia, Skull Base Neoplasms

NCT07258589 2025-12-02

TASTY-training

University Medical Center Groningen

Phase NA Recruiting
90 enrolled

Patients Who Are Treated With Tyrosine Kinase Inhibitors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡